Moderna MRNA Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$3.19B+4.9% | -$2.82B+20.8% | -$3.12B-27.7% | -$2.9B+52.3% | -$3.36B+45.7% | ||
| $235M+22.4% | $215M+13.8% | $208M-37.2% | $208M-60.6% | $192M-66.8% | ||
| $472M+6.5% | $483M+12.6% | $474M+17.3% | $461M+24.9% | $443M+33.8% | ||
| —— | —— | —— | —— | —— | ||
| $137M-85.9% | $192M-81.7% | $675M-9.9% | $793M+7.5% | $972M+23.0% | ||
| $1.19B— | $1.99B— | —— | —— | —— | ||
| —— | $600M— | $450M— | $300M— | $150M— | ||
| $607M+1,139% | $594M+907% | $13M+126% | $24M+120% | $49M+106% | ||
| $283M— | $668M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Moderna generate?
- Moderna (MRNA) generated -$3.4B in operating cash flow over the trailing twelve months.
- What is Moderna's free cash flow?
- After $137.0M of capital expenditures, Moderna's free cash flow was -$3.6B over the trailing twelve months, up 16.3% year over year.
- Where does Moderna's cash flow data come from?
- Every line is extracted from Moderna's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
